Dean Henry: What are the most common peptide mistakes?

Peptide ShowTuesday, October 13, 2026

Show Notes

Before you optimize your health, are you actually healthy?

Dean Henry has spent more than a decade working with peptides. He has also had enough of everyone calling themselves a biohacker.

As founder of UAE Peptides and Dn Research, and co-founder of Bioniq Lab, he works with individuals and practitioners navigating peptide protocols across Europe and the Middle East. His interest in health began long before peptides. A knee injury ended his football ambitions before his 16th birthday. Around the same time, he developed difficulty swallowing, with no clear explanation. Years later, he came to understand it as a stress response. That experience still shapes his approach: understand the person before choosing the protocol. Today, he sees people comparing stacks before understanding their own health, and questions how much experience some practitioners have with the compounds they recommend. Dean believes peptides could change medicine. But he wants people to get the basics right first, and a field full of personal success stories to invest in the human trials that can put those stories to the test. He explains:

■ The three mistakes he sees most often when people start using peptides ■ Why he puts gut health and bloodwork before copying someone else’s stack ■ How he distinguishes peptide bioregulators from other peptides ■ Why a medical qualification does not automatically mean peptide expertise ■ Why he believes the gray market will survive, even as regulated access expands Chapters

(00:00) - Intro

(01:35) - Dean’s story

(04:18) - Stress and the body

(06:10) - Peptides vs. bioregulators

(07:37) - The $100 million question

(09:34) - Three peptide mistakes

(11:14) - Gut health and peptides

(13:56) - Are you actually healthy?

(15:07) - Peptide access and regulation

(18:51) - Can doctors keep up?

(23:05) - The future of peptides

Watch the full episode on YouTube